GDC-0980

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for GDC-0980, covering 2016-08-10 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Participants Resistant to Aromatase Inhibitor Therapy [Phase 2]

See pricing